ArticleCardiovascular research2021

From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?

Paul M RidkerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.